Brussels, 15 May 2025
Yesterday at the C5 PFAS Summit, Paul Blondeau (Syensqo), representing FPG, joined fellow experts to discuss the indispensable role of fluoropolymers across critical sectors—including semiconductors, energy, healthcare, and defence.
On a Panel with Bruno Ameduri (CNRS) and Jonathan Pantanowitz (The Chemours Company), Paul presented the science-based evidence: fluoropolymers are non-toxic, non-mobile, non-bioavailable, and essential where performance and reliability are non-negotiable.
As discussions continue on broad PFAS restrictions, FPG reaffirms its commitment to responsible manufacturing and that fluoropolymers must be recognised for their unique set of properties and essential uses. Where no alternatives exist, restrictions risk undermining innovation, safety, and Europe’s strategic autonomy.